Logo image of 1ELX.MI

ESTEE LAUDER COMPANIES-CL A (1ELX.MI) Stock Fundamental Analysis

Europe - Euronext Milan - BIT:1ELX - US5184391044 - Common Stock

88.8 EUR
+0.8 (+0.91%)
Last: 12/9/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to 1ELX. 1ELX was compared to 16 industry peers in the Personal Care Products industry. 1ELX has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, 1ELX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

1ELX had positive earnings in the past year.
In the past year 1ELX had a positive cash flow from operations.
1ELX had positive earnings in 4 of the past 5 years.
In the past 5 years 1ELX always reported a positive cash flow from operatings.
1ELX.MI Yearly Net Income VS EBIT VS OCF VS FCF1ELX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B 3B

1.2 Ratios

The Return On Assets of 1ELX (-4.81%) is worse than 87.50% of its industry peers.
1ELX has a Return On Equity of -23.91%. This is amonst the worse of the industry: 1ELX underperforms 87.50% of its industry peers.
1ELX has a Return On Invested Capital of 4.69%. This is in the lower half of the industry: 1ELX underperforms 75.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for 1ELX is significantly below the industry average of 11.47%.
Industry RankSector Rank
ROA -4.81%
ROE -23.91%
ROIC 4.69%
ROA(3y)0.13%
ROA(5y)4.98%
ROE(3y)-1.32%
ROE(5y)17.24%
ROIC(3y)4.98%
ROIC(5y)7.4%
1ELX.MI Yearly ROA, ROE, ROIC1ELX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

1.3 Margins

The Operating Margin of 1ELX (8.72%) is worse than 62.50% of its industry peers.
1ELX's Operating Margin has declined in the last couple of years.
With an excellent Gross Margin value of 74.18%, 1ELX belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
In the last couple of years the Gross Margin of 1ELX has remained more or less at the same level.
Industry RankSector Rank
OM 8.72%
PM (TTM) N/A
GM 74.18%
OM growth 3Y-26.29%
OM growth 5Y-11.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.76%
GM growth 5Y-0.3%
1ELX.MI Yearly Profit, Operating, Gross Margins1ELX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 1ELX is destroying value.
1ELX has more shares outstanding than it did 1 year ago.
The number of shares outstanding for 1ELX has been reduced compared to 5 years ago.
The debt/assets ratio for 1ELX is higher compared to a year ago.
1ELX.MI Yearly Shares Outstanding1ELX.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
1ELX.MI Yearly Total Debt VS Total Assets1ELX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.2 Solvency

1ELX has an Altman-Z score of 3.36. This indicates that 1ELX is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of 1ELX (3.36) is comparable to the rest of the industry.
1ELX has a debt to FCF ratio of 7.01. This is a slightly negative value and a sign of low solvency as 1ELX would need 7.01 years to pay back of all of its debts.
1ELX has a Debt to FCF ratio of 7.01. This is in the lower half of the industry: 1ELX underperforms 62.50% of its industry peers.
A Debt/Equity ratio of 1.88 is on the high side and indicates that 1ELX has dependencies on debt financing.
1ELX's Debt to Equity ratio of 1.88 is on the low side compared to the rest of the industry. 1ELX is outperformed by 81.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.88
Debt/FCF 7.01
Altman-Z 3.36
ROIC/WACC0.62
WACC7.58%
1ELX.MI Yearly LT Debt VS Equity VS FCF1ELX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

2.3 Liquidity

1ELX has a Current Ratio of 1.32. This is a normal value and indicates that 1ELX is financially healthy and should not expect problems in meeting its short term obligations.
1ELX has a Current ratio of 1.32. This is in the better half of the industry: 1ELX outperforms 68.75% of its industry peers.
1ELX has a Quick Ratio of 1.32. This is a bad value and indicates that 1ELX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.92, 1ELX is in the better half of the industry, outperforming 68.75% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.92
1ELX.MI Yearly Current Assets VS Current Liabilites1ELX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

4

3. Growth

3.1 Past

1ELX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -36.12%.
Measured over the past years, 1ELX shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -18.22% on average per year.
1ELX shows a decrease in Revenue. In the last year, the revenue decreased by -6.53%.
1ELX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.04% yearly.
EPS 1Y (TTM)-36.12%
EPS 3Y-40.77%
EPS 5Y-18.22%
EPS Q2Q%128.57%
Revenue 1Y (TTM)-6.53%
Revenue growth 3Y-6.88%
Revenue growth 5Y0.04%
Sales Q2Q%3.57%

3.2 Future

The Earnings Per Share is expected to grow by 28.75% on average over the next years. This is a very strong growth
1ELX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.86% yearly.
EPS Next Y47.45%
EPS Next 2Y42.7%
EPS Next 3Y36.61%
EPS Next 5Y28.75%
Revenue Next Year4.25%
Revenue Next 2Y4.16%
Revenue Next 3Y4.41%
Revenue Next 5Y3.86%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
1ELX.MI Yearly Revenue VS Estimates1ELX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B
1ELX.MI Yearly EPS VS Estimates1ELX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

1

4. Valuation

4.1 Price/Earnings Ratio

1ELX is valuated quite expensively with a Price/Earnings ratio of 62.10.
Compared to the rest of the industry, the Price/Earnings ratio of 1ELX indicates a slightly more expensive valuation: 1ELX is more expensive than 75.00% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.54. 1ELX is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 34.06 indicates a quite expensive valuation of 1ELX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1ELX indicates a rather expensive valuation: 1ELX more expensive than 81.25% of the companies listed in the same industry.
1ELX's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 23.78.
Industry RankSector Rank
PE 62.1
Fwd PE 34.06
1ELX.MI Price Earnings VS Forward Price Earnings1ELX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, 1ELX is valued expensively inside the industry as 87.50% of the companies are valued cheaper.
Based on the Price/Free Cash Flow ratio, 1ELX is valued a bit more expensive than the industry average as 62.50% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 35.87
EV/EBITDA 20.47
1ELX.MI Per share data1ELX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as 1ELX's earnings are expected to grow with 36.61% in the coming years.
PEG (NY)1.31
PEG (5Y)N/A
EPS Next 2Y42.7%
EPS Next 3Y36.61%

2

5. Dividend

5.1 Amount

1ELX has a Yearly Dividend Yield of 1.35%.
1ELX's Dividend Yield is slightly below the industry average, which is at 2.78.
Compared to an average S&P500 Dividend Yield of 2.27, 1ELX's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.35%

5.2 History

The dividend of 1ELX has a limited annual growth rate of 4.31%.
Dividend Growth(5Y)4.31%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

The earnings of 1ELX are negative and hence is the payout ratio. 1ELX will probably not be able to sustain this dividend level.
1ELX's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-54.3%
EPS Next 2Y42.7%
EPS Next 3Y36.61%
1ELX.MI Yearly Income VS Free CF VS Dividend1ELX.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B

ESTEE LAUDER COMPANIES-CL A

BIT:1ELX (12/9/2025, 7:00:00 PM)

88.8

+0.8 (+0.91%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)10-30 2025-10-30/bmo
Earnings (Next)02-05 2026-02-05/bmo
Inst Owners91.7%
Inst Owner ChangeN/A
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap32.00B
Revenue(TTM)14.44B
Net Income(TTM)-930.00M
Analysts71.11
Price Target86.68 (-2.39%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.35%
Yearly Dividend1.48
Dividend Growth(5Y)4.31%
DP-54.3%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)38.2%
Min EPS beat(2)0.44%
Max EPS beat(2)75.96%
EPS beat(4)4
Avg EPS beat(4)65.82%
Min EPS beat(4)0.44%
Max EPS beat(4)99.01%
EPS beat(8)8
Avg EPS beat(8)73.78%
EPS beat(12)11
Avg EPS beat(12)86.84%
EPS beat(16)15
Avg EPS beat(16)68.13%
Revenue beat(2)0
Avg Revenue beat(2)-1.33%
Min Revenue beat(2)-2.6%
Max Revenue beat(2)-0.06%
Revenue beat(4)0
Avg Revenue beat(4)-1.67%
Min Revenue beat(4)-2.6%
Max Revenue beat(4)-0.06%
Revenue beat(8)0
Avg Revenue beat(8)-1.81%
Revenue beat(12)1
Avg Revenue beat(12)-1.68%
Revenue beat(16)2
Avg Revenue beat(16)-1.82%
PT rev (1m)11.94%
PT rev (3m)19.38%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.13%
EPS NY rev (1m)0.49%
EPS NY rev (3m)-0.77%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.07%
Revenue NY rev (1m)0.37%
Revenue NY rev (3m)0.95%
Valuation
Industry RankSector Rank
PE 62.1
Fwd PE 34.06
P/S 2.6
P/FCF 35.87
P/OCF 23.4
P/B 9.64
P/tB N/A
EV/EBITDA 20.47
EPS(TTM)1.43
EY1.61%
EPS(NY)2.61
Fwd EY2.94%
FCF(TTM)2.48
FCFY2.79%
OCF(TTM)3.8
OCFY4.27%
SpS34.21
BVpS9.22
TBVpS-4.58
PEG (NY)1.31
PEG (5Y)N/A
Graham Number17.22
Profitability
Industry RankSector Rank
ROA -4.81%
ROE -23.91%
ROCE 8.84%
ROIC 4.69%
ROICexc 5.55%
ROICexgc 10.76%
OM 8.72%
PM (TTM) N/A
GM 74.18%
FCFM 7.24%
ROA(3y)0.13%
ROA(5y)4.98%
ROE(3y)-1.32%
ROE(5y)17.24%
ROIC(3y)4.98%
ROIC(5y)7.4%
ROICexc(3y)6.37%
ROICexc(5y)9.94%
ROICexgc(3y)15.14%
ROICexgc(5y)22.74%
ROCE(3y)9.4%
ROCE(5y)13.97%
ROICexgc growth 3Y-33.25%
ROICexgc growth 5Y-18.06%
ROICexc growth 3Y-32.16%
ROICexc growth 5Y-18.64%
OM growth 3Y-26.29%
OM growth 5Y-11.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.76%
GM growth 5Y-0.3%
F-Score5
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 1.88
Debt/FCF 7.01
Debt/EBITDA 3.52
Cap/Depr 67.84%
Cap/Sales 3.86%
Interest Coverage 3.58
Cash Conversion 76.98%
Profit Quality N/A
Current Ratio 1.32
Quick Ratio 0.92
Altman-Z 3.36
F-Score5
WACC7.58%
ROIC/WACC0.62
Cap/Depr(3y)208.69%
Cap/Depr(5y)173.4%
Cap/Sales(3y)10.24%
Cap/Sales(5y)8.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-36.12%
EPS 3Y-40.77%
EPS 5Y-18.22%
EPS Q2Q%128.57%
EPS Next Y47.45%
EPS Next 2Y42.7%
EPS Next 3Y36.61%
EPS Next 5Y28.75%
Revenue 1Y (TTM)-6.53%
Revenue growth 3Y-6.88%
Revenue growth 5Y0.04%
Sales Q2Q%3.57%
Revenue Next Year4.25%
Revenue Next 2Y4.16%
Revenue Next 3Y4.41%
Revenue Next 5Y3.86%
EBIT growth 1Y-21.3%
EBIT growth 3Y-31.36%
EBIT growth 5Y-11.51%
EBIT Next Year106.84%
EBIT Next 3Y38.64%
EBIT Next 5Y27.48%
FCF growth 1Y171.62%
FCF growth 3Y-30.55%
FCF growth 5Y-16.56%
OCF growth 1Y-18.8%
OCF growth 3Y-25.21%
OCF growth 5Y-11.02%

ESTEE LAUDER COMPANIES-CL A / 1ELX.MI FAQ

What is the ChartMill fundamental rating of ESTEE LAUDER COMPANIES-CL A (1ELX.MI) stock?

ChartMill assigns a fundamental rating of 3 / 10 to 1ELX.MI.


What is the valuation status of ESTEE LAUDER COMPANIES-CL A (1ELX.MI) stock?

ChartMill assigns a valuation rating of 1 / 10 to ESTEE LAUDER COMPANIES-CL A (1ELX.MI). This can be considered as Overvalued.


Can you provide the profitability details for ESTEE LAUDER COMPANIES-CL A?

ESTEE LAUDER COMPANIES-CL A (1ELX.MI) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for 1ELX stock?

The Price/Earnings (PE) ratio for ESTEE LAUDER COMPANIES-CL A (1ELX.MI) is 62.1 and the Price/Book (PB) ratio is 9.64.


Can you provide the expected EPS growth for 1ELX stock?

The Earnings per Share (EPS) of ESTEE LAUDER COMPANIES-CL A (1ELX.MI) is expected to grow by 47.45% in the next year.